Hm Payson & CO Astrazeneca PLC Transaction History

Hm Payson & CO

$5.81 Billion
Q3 2024

A detailed history of Hm Payson & CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Hm Payson & CO holds 65,514 shares of AZN stock, worth $4.59 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

65,514

Previous 3,709 1666.35%

Holding current value

$4.59 Million

Previous $289,000 1666.09%

% of portfolio

0.09%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$76.67 - $87.62 $4.74 Million - $5.42 Million	61,805 Added 1666.35%	65,514 $5.1 Million
Q2 2024 Aug 13, 2024	BUY	$66.81 - $80.83 $935 - $1,131	14 Added 0.38%	3,709 $289,000
Q1 2024 Jun 20, 2024	BUY	$61.03 - $69.57 $305 - $347	5 Added 0.14%	3,695 $250,000
Q4 2023 Feb 13, 2024	SELL	$61.89 - $69.28 $57,990 - $64,915	-937 Reduced 20.25%	3,690 $248,000
Q3 2023 Nov 06, 2023	BUY	$64.85 - $71.7 $147,079 - $162,615	2,268 Added 96.14%	4,627 $313,000
Q2 2023 Jul 17, 2023	BUY	$69.91 - $75.81 $19,574 - $21,226	280 Added 13.47%	2,359 $168,000
Q1 2023 Apr 18, 2023	SELL	$63.15 - $71.6 $1,452 - $1,646	-23 Reduced 1.09%	2,079 $144,000
Q4 2022 Feb 06, 2023	BUY	$54.21 - $70.44 $4,282 - $5,564	79 Added 3.91%	2,102 $142,000
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $13,629 - $16,362	-230 Reduced 10.21%	2,023 $133,000
Q1 2022 May 12, 2022	BUY	$55.72 - $67.12 $111,440 - $134,240	2,000 Added 790.51%	2,253 $149,000
Q2 2021 Aug 17, 2021	SELL	$48.42 - $60.18 $25,517 - $31,714	-527 Reduced 67.56%	253 $15,000
Q1 2021 Jun 15, 2021	SELL	$47.16 - $54.44 $48,008 - $55,419	-1,018 Reduced 56.62%	780 $39,000
Q4 2020 Mar 10, 2021	BUY	$48.52 - $58.02 $60,552 - $72,408	1,248 Added 226.91%	1,798 $90,000
Q3 2020 Dec 21, 2020	BUY	$53.07 - $61.1 $29,188 - $33,605	550 New	550 $30,000

Others Institutions Holding AZN

# of Institutions

1,338

Shares Held

476M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $217B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

News

Stay updated on Hm Payson & CO with notifications on news.

Account